MAB846

Anti-Mumps Blend Antibody, fusion protein, clones 570-7A, 570-12G

Name: Anti-Mumps Blend Antibody, fusion protein, clones 570-7A, 570-12G
Brand: MM
Price: 403 USD

Chemicon^®, from mouse

Slide 1 of 1

Sign Into View Organizational & Contract Pricing

Select a Size

100 μG

$403.00

Check Cart for Availability

Request a Bulk Order

About This Item

UNSPSC Code:

12352203

eCl@ss:

32160702

NACRES:

NA.41

Key Documents

View All Documentation

biological source

mouse

Quality Level

300

antibody form

purified antibody

antibody product type

primary antibodies

clone

570-12G, monoclonal
570-7A, monoclonal

species reactivity

human

manufacturer/tradename

Chemicon^®

technique(s)

ELISA: suitable
immunofluorescence: suitable
western blot: suitable

isotype

IgG

shipped in

wet ice

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item	MAB8910	MAB8186	MAB80138
Sigma-Aldrich MAB846 Anti-Mumps Blend Antibody, fusion protein, clones 570-7A, 570-12G	Sigma-Aldrich MAB8910 Anti-Measles Blend Antibody, matrix protein, clones CV8, CV9	Sigma-Aldrich MAB8186 Anti-EBV EA-D-p52/50 Antibody, clone R3	Sigma-Aldrich MAB80138 Anti-Human Metapneumovirus Antibody, clone 507
antibody form purified antibody	antibody form purified antibody	antibody form purified immunoglobulin	antibody form purified antibody
species reactivity human	species reactivity human	species reactivity human	species reactivity human
biological source mouse	biological source mouse	biological source mouse	biological source mouse
clone 570-12G, monoclonal, 570-7A, monoclonal	clone CV8, monoclonal, CV9, monoclonal	clone R3, monoclonal	clone 507, monoclonal
shipped in wet ice	shipped in wet ice	shipped in wet ice	shipped in wet ice
technique(s) ELISA: suitable, western blot: suitable, immunofluorescence: suitable	technique(s) immunofluorescence: suitable	technique(s) ELISA: suitable, immunofluorescence: suitable, western blot: suitable	technique(s) ELISA: suitable, flow cytometry: suitable, immunofluorescence: suitable, western blot: suitable

Immunogen

Epitope: fusion protein

Application

Anti-Mumps Blend Antibody, fusion protein, clones 570-7A, 570-12G is an antibody against Mumps Blend for use in ELISA, IF & WB.

EIA at 1:1,000 - 3,000.

Immunofluorescence at 1:1,000 - 3,000.

Final working dilutions must be determined by end user.

Research Category
Infectious Diseases

Research Sub Category
Infectious Diseases - Viral

Biochem/physiol Actions

Specific for mumps and has shown reactivity to the mumps ENDERS strain.

Physical form

Format: Purified

In 0.02M phosphate buffer, 0.25 NaCl with 0.1% sodium azide.

Preparation Note

Maintain at +2-8°C for up to 12 months.

Other Notes

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Not finding the right product?

Try our Product Selector Tool.

Storage Class

10 - Combustible liquids

wgk_germany

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Sera from different age cohorts in Belgium show limited cross-neutralization between the mumps vaccine and outbreak strains.

T Vermeire et al.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 25(7), 907-907 (2018-12-07)

Mumps used to affect children between 2 and 15 years old. The mumps-measles-rubella (MMR) vaccine is available, with vaccine coverage rate of about 85% after two vaccine doses. Recently new mumps outbreaks have emerged in highly vaccinated populations; the causes for

Mumps and diabetes.

W P D LOGAN

Monthly bulletin of the Ministry of Health and the Public Health Laboratory Service null

Mumps Virus SH Protein Inhibits NF-κB Activation by Interacting with Tumor Necrosis Factor Receptor 1, Interleukin-1 Receptor 1, and Toll-Like Receptor 3 Complexes.

Stephanie Franz et al.

Journal of virology, 91(18) (2017-07-01)

The mumps virus (MuV) small hydrophobic protein (SH) is a type I membrane protein expressed in infected cells. SH has been reported to interfere with innate immunity by inhibiting tumor necrosis factor alpha (TNF-α)-mediated apoptosis and NF-κB activation. To elucidate

Multiplex reverse transcription-PCR for surveillance of influenza A and B viruses in England and Wales in 1995 and 1996.

J S Ellis et al.

Journal of clinical microbiology, 35(8), 2076-2082 (1997-08-01)

Multiple-target (multiplex) reverse transcription-PCR (RT-PCR) for detection, typing, and subtyping of the hemagglutinin gene of influenza type A (H3N2 and H1N1) and type B viruses was developed and applied prospectively to virological surveillance of influenza in England in the 1995-1996

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service